收听本期播客
阅读正文
In a world where science fiction is increasingly becoming reality, the pursuit of immortality has captured the attention of some of the most powerful and wealthy individuals. This controversial topic gained global interest recently when a conversation between China’s leader Xi Jinping and Russia’s Vladimir Putin was accidentally recorded. During their discussion, they explored the idea of achieving eternal life through breakthroughs in biotechnology, sparking debates about the ethics and implications of such a goal.
The concept of living forever may seem far-fetched, but for influential figures, it is a serious ambition. Earlier this month, Putin speculated that scientific progress, such as continuous organ transplants, could enable people to remain youthful or even live up to 150 years. This is not mere fantasy; billionaire investors from Silicon Valley and prominent political leaders are pouring money into research aimed at dramatically extending human life. They view ageing not as an inevitable part of life, but as a technical challenge that can be overcome with innovation and the right resources.
This movement builds on a century of medical advancements that have already extended average lifespans through better healthcare and public health initiatives. Today’s younger generations can expect to live longer and healthier lives than their ancestors. However, for some, this progress is insufficient. A growing number of technologists and affluent individuals are turning to extreme measures, such as biohacking—experimenting with their own bodies—and funding unusual experiments like blood transfusions from younger to older individuals in hopes of reversing ageing. In high-tech labs, scientists are driving what they call a ‘longevity revolution,’ envisioning a future where humans might integrate with artificial intelligence or rebuild their bodies to defy death.
The implications of this quest are profound. If life-extending treatments become available only to the elite, social inequality could worsen significantly. Additionally, there are concerns that resources are being diverted from public health programs that benefit the majority, as seen in recent policy shifts in the United States favoring technological innovation over support for the elderly. Yet, if successful, these advancements could eventually improve health and longevity for all.
This pursuit raises critical questions about fairness and the essence of human life. Should society prioritize extending life for a select few, or focus on enhancing the quality of life for everyone? The debate continues as science pushes the boundaries of what it means to be human.